drugset / Trial / NCT05429177
A First-in-Human Study of QY101 Ointment in Adult Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase I, randomized, double-blind, vehicle-controlled，single and multiple ascending dose study to assess the safety, tolerability, and pharmacokinetics of QY101 ointment in Chinese healthy subjects
Timeline
- Start
- 2022-06-08
- Primary completion
- 2023-06-21
- Completion
- 2023-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QY101 | Unknown | 0.1 % | Topical |
| Subject | QY101 | Unknown | 0.3 % | Topical |
| Subject | QY101 | Unknown | 0.5 % | Topical |
| Subject | QY101 | Unknown | 1 % | Topical |
Indications
No indication recorded.